Received Aug 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
pain on injection site at left arm; weakness left arm; swollen left arm; pain left arm; wrist pain left arm/elbow pain left arm; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced injection site pain (Verbatim: pain on injection site at left arm), weakness of arms (Verbatim: weakness left arm), swelling arm (Verbatim: swollen left arm), pain in arm (Verbatim: pain left arm) and wrist pain (Verbatim: wrist pain left arm/elbow pain left arm). The outcome of the injection site pain, weakness of arms, swelling arm, pain in arm and wrist pain were unknown. It was unknown if the reporter considered the injection site pain, weakness of arms, swelling arm, pain in arm and wrist pain to be related to Boostrix and Boostrix Pre-Filled Syringe Device. It was unknown if the company considered the injection site pain, weakness of arms, swelling arm, pain in arm and wrist pain to be related to Boostrix and Boostrix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 06-AUG-2025 The member of the public or patient called concerning some side effects on the Boostrix vaccine and any advised on them. The vaccination date and patient demographics were obtained in this call. No vaccine detail was obtained in this call. No further information was obtained in this call.